Markets have bounced back, but many quality stocks remain undervalued. Learn more about two high-yield dividend bargains like ...

Find out how genome sequencing has emerged and what the future holds for one of biotech's most important tools.

Exagen (XGN) is a speculative buy with promising growth in diagnostics, new lupus/RA tests, and potential positive EBITDA by ...

Alexandra Deignan; Head of Investor Relations; Lazard Inc. Peter Orszag; Chief Executive Officer; Lazard Inc. Mary Betsch; Chief Financial Officer; Lazard Inc. Evan ...

Angus Loten writes about enterprise information technology for The Wall Street Journal's New York bureau.

The Board of Directors of Motilal Oswal Financial Services Limited, at its meeting held today have approved the financial ...

The fund’s above-index exposure to biotech, a relatively volatile industry, has endured for more than a dozen years. It recently amounted to 9% of assets versus less than 3% in the Russell 1000 ...

The Board of Directors of L and T Finance Limited, at its meeting held today have approved the financial results of the ...

The university has emerged as a hub of innovation, research and sustainable development for future leaders Sher-e-Kashmir University of Agricultural Sciences ...